Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Saba Capital and Delaware Enhanced Global Dividend & Income Fund (DEX)

Delaware Enhanced Global Dividend & Income Fund (NYSE:DEX): Boaz Weinstein’s Saba Capital filed an amended 13D.

You can check out Saba Capital’s latest holdings and filings here.

Please follow Saba Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Saba Capital or update its stock holdings.

Boaz Weinstein
Boaz Weinstein
Saba Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Saba Capital Management 0 1,907,485 0 1,907,485 1,907,485 12.05%
Boaz R. Weinstein 0 1,907,485 0 1,907,485 1,907,485 12.05%
Boaz Weinstein
Boaz Weinstein
Saba Capital

Page 1 of 6 – SEC Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

DELAWARE ENHANCED GLOBAL DIVIDEND &
INCOME FUND

(Name of Issuer)

Comon Shares
(Title of Class of
Securities)

246060107
(CUSIP Number)

Saba Capital Management, L.P.
405 Lexington
Avenue

58th Floor
New York, NY 10174
Attention:
Michael D’Angelo

(212) 542-4635
(Name, Address and
Telephone Number of Person
Authorized to Receive Notices and Communications)

March 7, 2018
(Date of Event Which
Requires Filing of This Statement)

If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule
13d-1(g), check the following box. [X]

(Page 1 of 6 Pages)

______________________________
* The remainder of this
cover page shall be filled out for a reporting person’s initial filing on this
form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a
prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities
of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).

Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!

Page 2 of 6 – SEC Filing


CUSIP No. 246060107 SCHEDULE 13D Page 2 of 6 Pages

 

1 NAME OF REPORTING PERSON
         Saba Capital Management,
L.P.
2 CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP
(a)
[   ]
(b) [   ]
3 SEC USE ONLY
4 SOURCE OF FUNDS
         OO (see Item 3)
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e)
[   ]
6 CITIZENSHIP OR PLACE OF
ORGANIZATION
         Delaware
NUMBER OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
         -0-
8 SHARED VOTING POWER
        1,907,485
9 SOLE DISPOSITIVE POWER
         -0-
10 SHARED DISPOSITIVE POWER
 1,907,485
11 AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH PERSON
         1,907,485
12 CHECK IF THE AGGREGATE AMOUNT IN
ROW (11) EXCLUDES CERTAIN SHARES
[   ]
13 PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
         12.05%1
14 TYPE OF REPORTING PERSON
         PN; IA

______________________________
1 The percentages
used herein are calculated based upon 15,829,048 shares of common stock
outstanding as of 11/30/2017, as disclosed in the company’s Certified
Shareholder Report Form N-CSR filed 2/02/2018.

Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!

Page 3 of 6 – SEC Filing


CUSIP No. 246060107 SCHEDULE 13D Page 3 of 6 Pages

 

1 NAME OF
REPORTING PERSON
       Boaz R. Weinstein
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
(a)
[   ]
(b) [   ]
3 SEC
USE ONLY


4 SOURCE OF FUNDS
       OO (see Item 3)
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS
REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[
]
6 CITIZENSHIP OR PLACE OF ORGANIZATION
       United States
NUMBER OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING PERSON WITH:
7 SOLE
VOTING POWER
         -0-
8 SHARED
VOTING POWER
1,907,485
9 SOLE
DISPOSITIVE POWER
         -0-
10 SHARED
DISPOSITIVE POWER
         1,907,485
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
PERSON
       1,907,485
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES
[
]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
       12.05%1
14 TYPE OF REPORTING PERSON
       IN

______________________________
1 The percentages
used herein are calculated based upon 15,829,048 shares of common stock
outstanding as of 11/30/2017, as disclosed in the company’s Certified
Shareholder Report Form N-CSR filed 2/02/2018.

Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!

Page 4 of 6 – SEC Filing


CUSIP No. 246060107 SCHEDULE 13D Page 4 of 6 Pages

 

Item 1. SECURITY AND ISSUER

This Amendment No. 1 (“Amendment No. 1”) amends the
statement on Schedule 13D filed on January 10, 2018 (the “Original
Schedule 13D”, and as amended hereby, the “Schedule 13D”) with respect to
the common stock (the “Shares”), of Delaware Enhanced Global Dividend
& Income Fund (the “Issuer“). Capitalized terms used herein and
not otherwise defined in this Amendment No. 1 have the meanings set forth
in the Original Schedule 13D. This Amendment No. 1 amends Items 3, 4, 5
and 7 as set forth below.

Item 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Funds for the purchase of the Shares were derived from
the subscription proceeds from investors in the funds managed by Saba
Capital and the capital appreciation thereon and margin account borrowings
made in the ordinary course of business. In such instances, the positions
held in the margin accounts are pledged as collateral security for the
repayment of debit balances in the account, which may exist from time to
time. Since other securities are held in the margin accounts, it is not
possible to determine the amounts, if any, of margin used to purchase the
Shares reported herein. A total of $20,686,057 was paid to acquire the
Shares reported herein.

Item 4.

PURPOSE OF TRANSACTION

The Reporting Persons have engaged, and may continue to
engage, in discussions with management and the Board of Directors of the
Issuer regarding the long-term performance of the Issuer and the trading
of the Shares at a discount to the Issuer’s net asset value. On March 7,
2018, Saba Capital sent a letter to the Issuer containing a stockholder
proposal under Rule 14a-8 requesting that the Board of Directors consider
authorizing a self-tender for all outstanding Shares of the Issuer at or
close to net asset value; provided, however, if more than 50% of the
Issuer’s outstanding Shares are submitted for tender, the tender offer
should be cancelled and the Issuer should be liquidated or converted into
an open-end mutual fund. A copy of the letter is attached as Exhibit 1.

Item 5.

INTEREST IN SECURITIES OF THE ISSUER

 

(a)

See rows (11) and (13) of the cover pages to this
Schedule 13D for the aggregate number of Shares and percentages of the
Shares beneficially owned by each of the Reporting Persons. The
percentages used herein are calculated based upon 15,829,048 shares of
common stock outstanding as of November 30, 2017, as disclosed in the
company’s Certified Shareholder Report Form N-CSR filed February 2,
2018.

(b)

See rows (7) through (10) of the cover pages to this
Schedule 13D for the number of Shares as to which each Reporting Person
has the sole or shared power to vote or direct the vote and sole or shared
power to dispose or to direct the disposition.

 

Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!

Page 5 of 6 – SEC Filing


CUSIP No. 246060107 SCHEDULE 13D Page 5 of 6 Pages

 

(c)

There were no transactions in the Shares effected by Saba
Capital since the filing of the Original Schedule
13D.

 

Item 7. MATERIAL TO BE FILED AS
EXHIBITS

Item 7 of the Schedule 13D is hereby amended and
supplemented by the addition of the following:

Exhibit 1: Letter dated March 7, 2018 sent
by Saba Capital to the Issuer.

 

Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!

Page 6 of 6 – SEC Filing


CUSIP No. 246060107 SCHEDULE 13D Page 6 of 6 Pages

SIGNATURES

     After reasonable inquiry and to the best of his or
its knowledge and belief, each of the undersigned certifies that the information
set forth in this statement is true, complete and correct.

Date: March 7, 2018

SABA CAPITAL MANAGEMENT, L.P.
/s/
Michael D’Angelo
Name: Michael D’Angelo
Title: Chief Compliance Officer
BOAZ R. WEINSTEIN
/s/
Michael D’Angelo
Name: Michael D’Angelo
Title: Attorney-in-fact*

Pursuant to a power of attorney dated as of November 16, 2015,
which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed
by the Reporting Persons on December 28, 2015, accession number:
0001062993-15-006823


Follow Delaware Enhanced Global Dividend & Income Fund
Trade (DEX) Now!